HK Stock MarketDetailed Quotes

PW MEDTECH (01358)

Watchlist
  • 1.190
  • +0.010+0.85%
Not Open Apr 24 15:43 CST
1.75BMarket Cap16.76P/E (TTM)

PW MEDTECH (01358) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
7.10%823.51M
22.44%414.37M
13.90%768.9M
6.08%338.42M
25.75%675.08M
48.90%319.02M
97.80%536.83M
60.50%214.25M
9.72%271.4M
31.47%133.49M
Operating income
7.10%823.51M
22.44%414.37M
13.90%768.9M
6.08%338.42M
25.75%675.08M
48.90%319.02M
97.80%536.83M
60.50%214.25M
9.72%271.4M
31.47%133.49M
Cost of sales
-19.06%-416.05M
-33.69%-201.59M
-18.79%-349.46M
-6.03%-150.8M
-23.61%-294.19M
-52.66%-142.22M
-125.93%-238M
-82.62%-93.16M
-6.68%-105.34M
-21.39%-51.01M
Operating expenses
-19.06%-416.05M
-33.69%-201.59M
-18.79%-349.46M
-6.03%-150.8M
-23.61%-294.19M
-52.66%-142.22M
-125.93%-238M
-82.62%-93.16M
-6.68%-105.34M
-21.39%-51.01M
Gross profit
-2.86%407.46M
13.41%212.78M
10.12%419.45M
6.12%187.62M
27.46%380.9M
46.01%176.8M
79.95%298.83M
46.81%121.09M
11.74%166.06M
38.59%82.48M
Selling expenses
-14.95%-96.65M
-9.64%-43.77M
-10.51%-84.08M
-1.78%-39.92M
-12.77%-76.09M
-9.42%-39.22M
-9.21%-67.47M
-5.26%-35.84M
25.27%-61.78M
26.80%-34.05M
Administrative expenses
-7.99%-172.21M
-33.33%-83.46M
-33.98%-159.47M
-4.69%-62.6M
6.21%-119.02M
-30.29%-59.8M
-94.55%-126.9M
-70.49%-45.9M
-15.35%-65.23M
18.70%-26.92M
Research and development expenses
-9.71%-48.41M
-9.21%-22.49M
-7.27%-44.12M
10.35%-20.6M
-0.38%-41.13M
-67.79%-22.97M
-102.32%-40.98M
-85.88%-13.69M
55.75%-20.25M
31.12%-7.37M
Profit from asset sales
----
----
----
----
---6.1M
----
----
----
24.51%731.75M
495.22%731.75M
Revaluation surplus
-53.98%-1.82M
19.14%-321K
-1,837.70%-1.18M
-97.51%-397K
75.60%-61K
84.44%-201K
97.90%-250K
4.30%-1.29M
-578.84%-11.9M
90.35%-1.35M
-Changes in the fair value of investment property
-53.98%-1.82M
19.14%-321K
-1,837.70%-1.18M
-97.51%-397K
75.60%-61K
84.44%-201K
97.90%-250K
4.30%-1.29M
-578.84%-11.9M
90.35%-1.35M
Impairment and provision
97.53%5.28M
12.62%2.62M
--2.67M
--2.33M
----
----
----
----
-316.45%-40.69M
35.48%-4.09M
-Impairment of property, machinery and equipment
----
----
----
----
----
----
----
----
---40.69M
----
-Other impairment is provision
97.53%5.28M
12.62%2.62M
--2.67M
--2.33M
----
----
----
----
----
35.48%-4.09M
Special items of operating profit
-38.00%28.65M
-17.89%14.84M
-5.49%46.21M
-46.12%18.07M
-17.98%48.9M
-20.63%33.54M
446.14%59.61M
868.98%42.26M
19.89%-17.22M
14.49%-5.5M
Operating profit
-31.86%122.3M
-5.10%80.2M
-4.22%179.48M
-4.13%84.51M
52.55%187.4M
32.30%88.15M
-81.95%122.84M
-90.93%66.63M
31.34%680.73M
1,024.37%734.95M
Financing income
-15.07%42.69M
-17.51%22.92M
15.12%50.27M
37.18%27.79M
25.12%43.67M
53.90%20.26M
-38.47%34.9M
--13.16M
1,206.71%56.73M
----
Financing cost
----
----
----
----
----
----
----
----
----
--30.89M
Earning before tax
-28.19%164.99M
-8.17%103.12M
-0.57%229.75M
3.59%112.3M
46.48%231.07M
35.86%108.41M
-78.61%157.75M
-89.58%79.79M
17.69%737.46M
466.52%765.84M
Tax
20.12%-29.74M
11.57%-16.5M
-42.95%-37.23M
-61.79%-18.66M
9.82%-26.04M
-38.83%-11.54M
-1,847.13%-28.88M
-74.74%-8.31M
-68.28%1.65M
-179.67%-4.76M
After-tax profit from continuing operations
-29.75%135.25M
-7.50%86.62M
-6.10%192.52M
-3.34%93.64M
59.10%205.02M
35.52%96.87M
-82.56%128.87M
-90.61%71.49M
16.98%739.12M
439.20%761.09M
Earning after tax
-29.75%135.25M
-7.50%86.62M
-6.10%192.52M
-3.34%93.64M
59.10%205.02M
35.52%96.87M
-82.56%128.87M
-90.61%71.49M
16.98%739.12M
439.20%761.09M
Minority profit
-2.07%40.88M
-11.96%20.62M
-19.48%41.74M
-9.56%23.42M
127.11%51.84M
138.53%25.9M
760,966.67%22.83M
542,950.00%10.86M
0.00%-3K
0.00%-2K
Profit attributable to shareholders
-37.41%94.37M
-6.01%66M
-1.57%150.78M
-1.07%70.22M
44.46%153.18M
17.07%70.98M
-85.65%106.04M
-92.03%60.63M
16.98%739.12M
439.20%761.09M
Basic earnings per share
-36.03%0.0625
-1.11%0.0444
-0.10%0.0977
-0.88%0.0449
44.46%0.0978
17.05%0.0453
-85.63%0.0677
-92.02%0.0387
16.99%0.471
439.49%0.485
Diluted earnings per share
-36.03%0.0625
-1.11%0.0444
-0.10%0.0977
-0.88%0.0449
44.46%0.0978
17.05%0.0453
-85.63%0.0677
-92.02%0.0387
16.99%0.471
439.49%0.485
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
Hong Kong Lixin Dehao Certified Public Accountants Limited
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover 7.10%823.51M22.44%414.37M13.90%768.9M6.08%338.42M25.75%675.08M48.90%319.02M97.80%536.83M60.50%214.25M9.72%271.4M31.47%133.49M
Operating income 7.10%823.51M22.44%414.37M13.90%768.9M6.08%338.42M25.75%675.08M48.90%319.02M97.80%536.83M60.50%214.25M9.72%271.4M31.47%133.49M
Cost of sales -19.06%-416.05M-33.69%-201.59M-18.79%-349.46M-6.03%-150.8M-23.61%-294.19M-52.66%-142.22M-125.93%-238M-82.62%-93.16M-6.68%-105.34M-21.39%-51.01M
Operating expenses -19.06%-416.05M-33.69%-201.59M-18.79%-349.46M-6.03%-150.8M-23.61%-294.19M-52.66%-142.22M-125.93%-238M-82.62%-93.16M-6.68%-105.34M-21.39%-51.01M
Gross profit -2.86%407.46M13.41%212.78M10.12%419.45M6.12%187.62M27.46%380.9M46.01%176.8M79.95%298.83M46.81%121.09M11.74%166.06M38.59%82.48M
Selling expenses -14.95%-96.65M-9.64%-43.77M-10.51%-84.08M-1.78%-39.92M-12.77%-76.09M-9.42%-39.22M-9.21%-67.47M-5.26%-35.84M25.27%-61.78M26.80%-34.05M
Administrative expenses -7.99%-172.21M-33.33%-83.46M-33.98%-159.47M-4.69%-62.6M6.21%-119.02M-30.29%-59.8M-94.55%-126.9M-70.49%-45.9M-15.35%-65.23M18.70%-26.92M
Research and development expenses -9.71%-48.41M-9.21%-22.49M-7.27%-44.12M10.35%-20.6M-0.38%-41.13M-67.79%-22.97M-102.32%-40.98M-85.88%-13.69M55.75%-20.25M31.12%-7.37M
Profit from asset sales -------------------6.1M------------24.51%731.75M495.22%731.75M
Revaluation surplus -53.98%-1.82M19.14%-321K-1,837.70%-1.18M-97.51%-397K75.60%-61K84.44%-201K97.90%-250K4.30%-1.29M-578.84%-11.9M90.35%-1.35M
-Changes in the fair value of investment property -53.98%-1.82M19.14%-321K-1,837.70%-1.18M-97.51%-397K75.60%-61K84.44%-201K97.90%-250K4.30%-1.29M-578.84%-11.9M90.35%-1.35M
Impairment and provision 97.53%5.28M12.62%2.62M--2.67M--2.33M-----------------316.45%-40.69M35.48%-4.09M
-Impairment of property, machinery and equipment -----------------------------------40.69M----
-Other impairment is provision 97.53%5.28M12.62%2.62M--2.67M--2.33M--------------------35.48%-4.09M
Special items of operating profit -38.00%28.65M-17.89%14.84M-5.49%46.21M-46.12%18.07M-17.98%48.9M-20.63%33.54M446.14%59.61M868.98%42.26M19.89%-17.22M14.49%-5.5M
Operating profit -31.86%122.3M-5.10%80.2M-4.22%179.48M-4.13%84.51M52.55%187.4M32.30%88.15M-81.95%122.84M-90.93%66.63M31.34%680.73M1,024.37%734.95M
Financing income -15.07%42.69M-17.51%22.92M15.12%50.27M37.18%27.79M25.12%43.67M53.90%20.26M-38.47%34.9M--13.16M1,206.71%56.73M----
Financing cost --------------------------------------30.89M
Earning before tax -28.19%164.99M-8.17%103.12M-0.57%229.75M3.59%112.3M46.48%231.07M35.86%108.41M-78.61%157.75M-89.58%79.79M17.69%737.46M466.52%765.84M
Tax 20.12%-29.74M11.57%-16.5M-42.95%-37.23M-61.79%-18.66M9.82%-26.04M-38.83%-11.54M-1,847.13%-28.88M-74.74%-8.31M-68.28%1.65M-179.67%-4.76M
After-tax profit from continuing operations -29.75%135.25M-7.50%86.62M-6.10%192.52M-3.34%93.64M59.10%205.02M35.52%96.87M-82.56%128.87M-90.61%71.49M16.98%739.12M439.20%761.09M
Earning after tax -29.75%135.25M-7.50%86.62M-6.10%192.52M-3.34%93.64M59.10%205.02M35.52%96.87M-82.56%128.87M-90.61%71.49M16.98%739.12M439.20%761.09M
Minority profit -2.07%40.88M-11.96%20.62M-19.48%41.74M-9.56%23.42M127.11%51.84M138.53%25.9M760,966.67%22.83M542,950.00%10.86M0.00%-3K0.00%-2K
Profit attributable to shareholders -37.41%94.37M-6.01%66M-1.57%150.78M-1.07%70.22M44.46%153.18M17.07%70.98M-85.65%106.04M-92.03%60.63M16.98%739.12M439.20%761.09M
Basic earnings per share -36.03%0.0625-1.11%0.0444-0.10%0.0977-0.88%0.044944.46%0.097817.05%0.0453-85.63%0.0677-92.02%0.038716.99%0.471439.49%0.485
Diluted earnings per share -36.03%0.0625-1.11%0.0444-0.10%0.0977-0.88%0.044944.46%0.097817.05%0.0453-85.63%0.0677-92.02%0.038716.99%0.471439.49%0.485
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ----Hong Kong Lixin Dehao Certified Public Accountants Limited--Hong Kong Lixin Dehao Certified Public Accountants Limited--Hong Kong Lixin Dehao Certified Public Accountants Limited--Hong Kong Lixin Dehao Certified Public Accountants Limited--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More